Frontlight ResearchEarly access
Taking people in United StatesNo phase
REFLECT Scoliosis System Post Approval Study
Key facts
- Who runs it
- Globus Medical Inc
- Where
- New York and Rochester, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 8 Apr 2024
- Expected to end
- 31 Mar 2032
- Type of study
- Interventional
- Treatments tested
- REFLECT Scoliosis Correction System
- Record updated
- 13 February 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Diagnosis of progressive idiopathic scoliosis
- Preoperative major Cobb angle 30°-65°
- Preoperative flexibility to ≤30° on side bending radiograph (left or right)
- Skeletally immature at the time of surgery with Risser sign <5 or Sanders score <8
- Osseous structure dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging
- Failed or intolerant to bracing
- Signed informed consent and/or assent forms specific to this study
Who cannot take part
- Prior spinal surgery at the level(s) to be treated
- Active participation in a drug or device study that is more than minimal risk such that participation would confound the measurements of the present study
- Presence of any systemic infection, local infection, or skin compromise at the surgical site
- Any medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the implant materials, and patient's unwillingness or inability to cooperate with post-operative care instructions
- Documented poor bone quality, defined as a T-score of -1.5 or less
- Unwillingness, inability, or living situation (e.g. custody arrangements, homelessness, detention) that would preclude ability to return to the study site for follow-up visits as described in protocol and Informed Consent
This trial is currently available in United States.
- New York UniversityNew York, United StatesContact: Rebecca SmithEnrolling by invitation
- Mayo ClinicRochester, United StatesContact: Angie SeversonTaking people
About the trial
What the trial wants to find out
The purpose of this multi-center, prospective, single-arm registry Post-Approval Study (PAS) is to evaluate the radiographic and clinical outcomes of 100 patients with idiopathic scoliosis treated with the REFLECT™ Scoliosis Correction System, as a condition of HDE approval
The group in the trial
- REFLECTOther group
Enrolled patients are treated with the REFLECT Scoliosis System. This is an HDE-approved device.
Treatment: REFLECT Scoliosis Correction System
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective, Single-Arm, Multi-Center, Registry Post-Approval Study of Growth Modulation in the Treatment of Idiopathic Scoliosis With the REFLECT™ Scoliosis Correction System
- Record updated
- 13 February 2026